Profitability Ratios
| Ratio |
Value |
| GP Margin |
95.5% |
| EBIT Margin |
-111.5% |
| EBITDA Margin |
-107.0% |
| Operating Margin |
-111.5% |
| Pretax Margin |
-97.9% |
| Cont. Ops Margin |
-97.9% |
| Net Margin |
-97.9% |
| Bottom Line Margin |
-97.9% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
6.64 |
| Quick Ratio |
6.64 |
| Solvency Ratio |
-1.098 |
| Cash Ratio |
6.35 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
0.13 |
| Forward PEG |
0.13 |
| Price/Book |
0.78 |
| Price/Sales |
2.50 |
| Price/FCF |
-2.26 |
| Price/Op Cash Flow |
-2.26 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.0922 |
| Debt/Equity |
0.1168 |
| Debt/Capital |
0.1046 |
| Long-Term Debt/Capital |
0.0000 |
| Financial Leverage |
1.27 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
0.30 |
| Operating Cash Flow Ratio |
-2.042 |
| Operating Cash Flow/Sales |
-110.5% |
| Free Cash Flow/Operating Cash Flow |
100.0% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
-17.07 |
| Interest Coverage |
0.0000 |
| Short-Term Operating Cash Flow Coverage |
-17.62 |
| Operating Cash Flow Coverage |
-2.97 |
| Capital Expenditure Coverage |
-322.92 |
| Dividend + Capital Expenditure Coverage |
-322.92 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
2.45 |
| EPS |
-2.402 |
| Debt/Share |
0.9128 |
| Cash/Share |
8.43 |
| Book Value/Share |
7.81 |
| Tangible BV/Share |
7.81 |
| Equity/Share |
7.81 |
| Operating Cash Flow/Share |
-2.712 |
| Capital Expenditure/Share |
0.008 |
| FCF/Share |
-2.712 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.000 |
| Earnings Before Tax/EBIT |
0.878 |
| Price/Fair Value |
0.78 |
| Debt/Market Cap |
0.0251 |
| Effective Tax Rate |
0.0% |
| Enterprise Value Multiple |
0.53 |
ARCT - Arcturus Therapeutics Holdings Inc.